cefuroxime has been researched along with Blood Poisoning in 36 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "FT is more effective than cefuroxime, which is commonly used during the perioperative period of urinary stones, and exerts a high antibacterial effect on these internal bacteria, and effectively reduces the probability of infection and sepsis after urinary stone surgery." | 5.34 | Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones. ( Hu, Z; Lei, Y; Liu, C; Song, F; Zhang, J, 2020) |
| "A series of patients aged 3 months to 15 years who fulfilled strict criteria for bacterial pneumonia, other respiratory infections, sepsis-like infections, and other acute infections were prospectively randomized to receive parenteral penicillin or cefuroxime randomly for 4 or 7 days." | 5.09 | Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. ( Kallio, MJ; Peltola, H; Vuori-Holopainen, E, 2001) |
| " influenzae type b preseptal cellulitis is reported who initially responded to treatment with intravenous cefuroxime and oral cefaclor." | 3.67 | Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis. ( Barson, WJ; Brady, MT; Cannon, HJ; Grossman, LK, 1987) |
| "Cefuroxime was chosen as the PBP-3-active antibiotic and tobramycin represented the aminoglycosides." | 1.56 | Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model. ( Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P, 2020) |
| "A working diagnosis of severe septicemia with acute meningoencephalitis was then made and the patient was started on IV Cephtriaxone (2 g) twice daily." | 1.46 | A case report: primary amoebic meningoencephalitis in a young Zambian adult. ( Chomba, M; Fwoloshi, S; Mucheleng'anga, LA; Mutengo, MM; Ngulube, J, 2017) |
| "All animals developed severe sepsis/septic shock." | 1.40 | Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model. ( Castegren, M; Jonsson, AB; Larsson, A; Lipcsey, M; Maudsdotter, L; Sjölin, J; Skorup, P, 2014) |
| "Sepsis was higher in neonates with fever and hypothermia (p=0." | 1.38 | Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome. ( Fredrick, F; Massawe, A; Matee, MI; Mhada, TV, 2012) |
| " The pharmacokinetic profile of cefuroxime exhibited both one and two compartmental distribution." | 1.35 | Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure. ( Asseff, IL; Guillé, GP; Olguín, HJ; Pérez, AG; Quesada, AC; Saldaña, NG; Vieyra, AC, 2008) |
| "All the babies had septic arthritis and ten cases had osteomyelitis in addition: multiple joint involvement occurred in 50% of cases." | 1.29 | Klebsiella septicaemia, osteomyelitis and septic arthritis in neonates in Ibadan, Nigeria. ( Adeyemo, AA; Akindele, JA; Omokhodion, SI, 1993) |
| "Treatment with cefuroxime appears to be a safe and effective therapy for pediatric soft-tissue infections due to H influenzae and S pneumoniae." | 1.27 | Cefuroxime therapy for bacteremic soft-tissue infections in children. ( Barson, WJ; Brady, MT; Hribar, MM; Marcon, MJ; Miller, MA; Pacini, DL; Powell, DA, 1985) |
| "Cefuroxime was active against all the gram-positive bacteria isolated from our patients as well as most of the gram-negatives." | 1.26 | Cefuroxime in soft tissue infections and septicaemia. ( Dornbusch, K; Hugo, H; Sterner, G, 1980) |
| "pneumoniae was inhibited in concentration of less than 3." | 1.26 | [Laboratory and clinical studies on cefuroxime (author's transl)]. ( Hiromatsu, K; Kotani, Y; Nishimura, T; Tabuki, K; Takashima, T, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (38.89) | 18.7374 |
| 1990's | 6 (16.67) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 6 (16.67) | 24.3611 |
| 2020's | 4 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Jacewicz, M | 1 |
| Günzel, K | 1 |
| Rud, E | 1 |
| Sandbæk, G | 1 |
| Magheli, A | 1 |
| Busch, J | 1 |
| Hinz, S | 1 |
| Baco, E | 1 |
| Owusu, M | 1 |
| Acheampong, G | 1 |
| Annan, A | 1 |
| Marfo, KS | 1 |
| Osei, I | 1 |
| Amuasi, J | 1 |
| Sarpong, N | 1 |
| Im, J | 1 |
| Mogeni, OD | 1 |
| Chiang, HY | 1 |
| Kuo, CH | 1 |
| Jeon, HJ | 1 |
| Panzner, U | 1 |
| Park, SE | 1 |
| Marks, F | 1 |
| Owusu-Dabo, E | 1 |
| Adu-Sarkodie, Y | 1 |
| Song, F | 1 |
| Liu, C | 1 |
| Zhang, J | 1 |
| Lei, Y | 1 |
| Hu, Z | 1 |
| Skorup, P | 3 |
| Maudsdotter, L | 3 |
| Lipcsey, M | 3 |
| Larsson, A | 3 |
| Sjölin, J | 3 |
| de Vries Schultink, AHM | 1 |
| Sallevelt, BTGM | 1 |
| Meinders, AJ | 1 |
| van de Garde, EMW | 1 |
| Roescher, N | 1 |
| Chomba, M | 1 |
| Mucheleng'anga, LA | 1 |
| Fwoloshi, S | 1 |
| Ngulube, J | 1 |
| Mutengo, MM | 1 |
| Bauer, M | 1 |
| Krüger, R | 1 |
| Kölsch, U | 1 |
| Unterwalder, N | 1 |
| Meisel, C | 1 |
| Wahn, V | 1 |
| von Bernuth, H | 1 |
| Tano, E | 1 |
| Castegren, M | 2 |
| Jonsson, AB | 1 |
| Mhada, TV | 1 |
| Fredrick, F | 1 |
| Matee, MI | 1 |
| Massawe, A | 1 |
| Holak, H | 1 |
| Becker, R | 1 |
| Holak, S | 1 |
| Bauhofer, A | 1 |
| Celik, I | 1 |
| Plaul, U | 1 |
| Wulf, H | 1 |
| Torossian, A | 1 |
| Olguín, HJ | 1 |
| Asseff, IL | 1 |
| Vieyra, AC | 1 |
| Pérez, AG | 1 |
| Saldaña, NG | 1 |
| Quesada, AC | 1 |
| Guillé, GP | 1 |
| Geroulanos, S | 1 |
| Donfried, B | 1 |
| Turina, M | 1 |
| Mitchell-Jones, PJ | 1 |
| Sankey, RJ | 1 |
| Seufert, RM | 1 |
| Germann, G | 1 |
| Böttcher, W | 1 |
| Jafusco, F | 1 |
| Ansanelli, V | 1 |
| Di Lena, C | 1 |
| Marget, W | 1 |
| Belohradsky, BH | 1 |
| Roos, R | 1 |
| Hugo, H | 1 |
| Dornbusch, K | 2 |
| Sterner, G | 1 |
| Adeyemo, AA | 1 |
| Akindele, JA | 1 |
| Omokhodion, SI | 1 |
| Galloway, A | 1 |
| Glesson, HK | 1 |
| Thomas, LR | 1 |
| Baden, L | 1 |
| Zaleznik, DF | 1 |
| Peltola, H | 1 |
| Vuori-Holopainen, E | 1 |
| Kallio, MJ | 1 |
| Pérez-Trallero, E | 1 |
| Alkorta, M | 1 |
| Giménez, MJ | 1 |
| Vicente, D | 1 |
| Aguilar, L | 1 |
| Maw, A | 1 |
| Eu, KW | 1 |
| Seow-Choen, F | 1 |
| Nishimura, T | 1 |
| Hiromatsu, K | 1 |
| Takashima, T | 1 |
| Tabuki, K | 1 |
| Kotani, Y | 1 |
| Dofferhoff, AS | 1 |
| Bom, VJ | 1 |
| van Ingen, J | 1 |
| de Vries-Hospers, HG | 1 |
| Hazenberg, BP | 1 |
| van der Meer, J | 1 |
| Mulder, PO | 1 |
| Weits, J | 1 |
| Wu, SW | 1 |
| Göransson, E | 1 |
| Ransjö, U | 1 |
| Kronvall, G | 1 |
| Gothefors, L | 1 |
| Choo, PW | 1 |
| Gantz, NM | 1 |
| Huovinen, S | 1 |
| Huovinen, P | 1 |
| Torniainen, K | 1 |
| Jacoby, GA | 1 |
| Rödjer, S | 1 |
| Alestig, K | 1 |
| Bergmark, J | 1 |
| Bergström, T | 1 |
| Hultberg, B | 1 |
| Jagenburg, R | 1 |
| Olaisson, L | 1 |
| Trollfors, B | 1 |
| Westin, J | 1 |
| Morran, C | 1 |
| Greig, J | 1 |
| Gunn, R | 1 |
| Mason, B | 1 |
| Sleigh, D | 1 |
| Haddock, G | 1 |
| McArdle, C | 1 |
| Brady, MT | 2 |
| Barson, WJ | 2 |
| Cannon, HJ | 1 |
| Grossman, LK | 1 |
| Frimodt-Møller, N | 1 |
| Thomsen, VF | 1 |
| Miller, MA | 1 |
| Marcon, MJ | 1 |
| Hribar, MM | 1 |
| Pacini, DL | 1 |
| Powell, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Prospective Randomized Trial of Antibiotic Prophylaxis Versus None Before Transperineal MRI-TRUS Fusion Guided Prostate Biopsy[NCT04146142] | 550 participants (Actual) | Interventional | 2019-11-11 | Completed | |||
| Tolerance and Efficacy of Amiklin Administration During Nosocomial Infections Complicating COVID-19 in the ICU[NCT05511129] | 1,053 participants (Actual) | Observational | 2022-05-12 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 trials available for cefuroxime and Blood Poisoning
| Article | Year |
|---|---|
Antibiotic prophylaxis versus no antibiotic prophylaxis in transperineal prostate biopsies (NORAPP): a randomised, open-label, non-inferiority trial.
Topics: Anti-Bacterial Agents; Biopsy; Cefuroxime; Humans; Male; Prostate; Sepsis; Urinary Tract Infections | 2022 |
Antibacterial effect of fosfomycin tromethamine on the bacteria inside urinary infection stones.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Cefuroxime; Colony Count, Micr | 2020 |
Plasma levels of ceftriaxone in cardiovascular surgery.
Topics: Bacterial Infections; Cardiac Surgical Procedures; Cefotaxime; Ceftriaxone; Cefuroxime; Clinical Tri | 1984 |
[Perioperative antibiotic prophylaxis in elective splenectomy. A randomized prospective study].
Topics: Adult; Cefuroxime; Cephalosporins; Humans; Male; Middle Aged; Pneumonia; Postoperative Complications | 1984 |
Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study.
Topics: Adolescent; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Female; Humans; Infant; Male; | 2001 |
Treatment of septicaemia in immunocompromised patients with ceftazidime or with tobramycin and cefuroxime, with special reference to renal effects.
Topics: Adult; Aged; Ceftazidime; Cefuroxime; Female; Humans; Immunologic Deficiency Syndromes; Kidney; Kidn | 1987 |
A comparison of cefuroxime and cefotetan in the prevention of wound sepsis after gastrointestinal surgery.
Topics: Bacteria; Cefotetan; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Gastrointestinal Diseases | 1987 |
29 other studies available for cefuroxime and Blood Poisoning
| Article | Year |
|---|---|
Ralstonia mannitolilytica sepsis: a case report.
Topics: Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Female; Ghana; Gram-Negative Bacterial Infectio | 2019 |
Mode of bacterial killing affects the inflammatory response and associated organ dysfunctions in a porcine E. coli intensive care sepsis model.
Topics: Animals; Cefuroxime; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infectio | 2020 |
The need for gentamicin adjunctive to cefuroxime as empirical sepsis therapy: a local protocol evaluation.
Topics: Anti-Bacterial Agents; Cefuroxime; Cephalosporins; Gentamicins; Humans; Sepsis | 2021 |
A case report: primary amoebic meningoencephalitis in a young Zambian adult.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Cefuroxime; Central Nervous System Protozoal Infecti | 2017 |
Antibiotic Prophylaxis, Immunoglobulin Substitution and Supportive Measures Prevent Infections in MECP2 Duplication Syndrome.
Topics: Administration, Intravenous; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefuroxime; Humans; IgA | 2018 |
Dynamics of Endotoxin, Inflammatory Variables, and Organ Dysfunction After Treatment With Antibiotics in an Escherichia coli Porcine Intensive Care Sepsis Model.
Topics: Animals; Anti-Bacterial Agents; Cefuroxime; Disease Models, Animal; Drug Therapy, Combination; Endot | 2018 |
Beneficial antimicrobial effect of the addition of an aminoglycoside to a β-lactam antibiotic in an E. coli porcine intensive care severe sepsis model.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Load; Cefuroxime; Critical Care; Disease Model | 2014 |
Neonatal sepsis at Muhimbili National Hospital, Dar es Salaam, Tanzania; aetiology, antimicrobial sensitivity pattern and clinical outcome.
Topics: Amikacin; Ampicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cloxacillin; Escherichia coli; | 2012 |
[Long-term follow-up of bilateral endogenous Klebsiella endophthalmitis].
Topics: Abscess; Aged; Cefotaxime; Cefuroxime; Drug Therapy, Combination; Endophthalmitis; Follow-Up Studies | 2003 |
Effects of G-CSF and antibiotic prophylaxis in a 2 x 2 factorial design on outcome in septic rats.
Topics: Abdomen; Animals; Antibiotic Prophylaxis; Cefuroxime; Clinical Trials as Topic; Disease Models, Anim | 2004 |
Effect of severity disease on the pharmacokinetics of cefuroxime in children with multiple organ system failure.
Topics: Adolescent; Alanine Transaminase; Algorithms; Area Under Curve; Aspartate Aminotransferases; Cefurox | 2008 |
A case of recurrent salmonella septicaemia in an infant.
Topics: Cefuroxime; Cephalosporins; Chloramphenicol; Drug Combinations; Female; Humans; IgA Deficiency; Infa | 1984 |
[Experience with the therapeutic use of cefuroxime in neonatology].
Topics: Bacterial Infections; Cefuroxime; Cephalosporins; Gastroenteritis; Humans; Infant, Newborn; Infant, | 1981 |
Guidelines for adequate chemotherapeutic dosage in newborns and infants with septicaemia and meningitis.
Topics: Amikacin; Anti-Bacterial Agents; Cefuroxime; Colistin; Dose-Response Relationship, Drug; Humans; Inf | 1980 |
Cefuroxime in soft tissue infections and septicaemia.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefuroxime; Cephalosporins; Drug Tolerance; Female; H | 1980 |
Klebsiella septicaemia, osteomyelitis and septic arthritis in neonates in Ibadan, Nigeria.
Topics: Arthritis, Infectious; Ceftazidime; Cefuroxime; Cloxacillin; Cross Infection; Cross-Sectional Studie | 1993 |
Survival following group A streptococcal septicaemia in a centenarian.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amoxicillin; Cefuroxime; Cephalosporins; Female; Huma | 1999 |
Clinical problem-solving. Chest pain with a surprising course.
Topics: Aged; Anuria; Cefuroxime; Cephalosporins; Chest Pain; Cholecystitis; Clostridium Infections; Clostri | 1999 |
Prediction of in-vivo efficacy by in-vitro early bactericidal activity with oral beta-lactams, in a dose-ranging immunocompetent mouse sepsis model, using strains of Streptococcus pneumoniae with decreasing susceptibilities to penicillin.
Topics: Amoxicillin; Animals; Area Under Curve; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Diseas | 2001 |
Retroperitoneal sepsis complicating stapled hemorrhoidectomy: report of a case and review of the literature.
Topics: Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Hemorrhoids; Humans; Male; Metronidazole; | 2002 |
[Laboratory and clinical studies on cefuroxime (author's transl)].
Topics: Adolescent; Bacterial Infections; Cefuroxime; Cephalosporins; Child; Child, Preschool; Common Bile D | 1979 |
Patterns of cytokines, plasma endotoxin, and acute phase proteins during the treatment of severe sepsis in humans.
Topics: Acute-Phase Proteins; Cefuroxime; Cilastatin; Drug Therapy, Combination; Endotoxins; Female; Humans; | 1991 |
Characterization of Klebsiella oxytoca septicaemia isolates resistant to aztreonam and cefuroxime.
Topics: Aztreonam; beta-Lactamases; Cefuroxime; DNA, Bacterial; Drug Resistance, Microbial; Humans; Klebsiel | 1991 |
[Cefuroxime has a good effect in severe infections in children].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefuroxime; Child, Preschool; Humans; Infant; Infant, Newbor | 1990 |
Branhamella catarrhalis pneumonia with bacteremia.
Topics: Aged; Ceftriaxone; Cefuroxime; Cross Infection; Female; Humans; Moraxella catarrhalis; Pneumonia; Se | 1989 |
Evaluation of plasmid-encoded beta-lactamase resistance in Escherichia coli blood culture isolates.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefuroxime; Drug Resistance, Microbial; Enteroba | 1988 |
Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis.
Topics: Cefaclor; Ceftriaxone; Cefuroxime; Cellulitis; Cephalexin; Drug Resistance, Microbial; Haemophilus I | 1987 |
The pneumococcus and the mouse protection test: inoculum, dosage and timing.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Dose-Response Relationship, Drug; Female; In | 1986 |
Cefuroxime therapy for bacteremic soft-tissue infections in children.
Topics: beta-Lactamases; Cefuroxime; Cellulitis; Cephalosporins; Child, Preschool; Drug Resistance, Microbia | 1985 |